Beneficial effects of minocycline on cuprizone induced cortical demyelination

Neurochemical Research

Volumn 35, Issue 9, 2010, Pages 1422-1433

  Skripuletz, Thomas ^a   Miller, Elvira ^a   Moharregh Khiabani, Darius ^a   Blank, Alexander ^a   Pul, Refik ^a   Gudi, Viktoria ^b   Trebst, Corinna ^a   Stangel, Martin ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Animal model C57BL 6 mice; Myelin; Remyelination

Indexed keywords

CUPRIZONE; MINOCYCLINE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; C57BL 6 MOUSE; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; COORDINATION DISORDER; CORPUS CALLOSUM; DEMYELINATION; GRAY MATTER; MALE; MICROGLIA; MOTOR COORDINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; WALKING; WHITE MATTER;

ANIMALS; ANTI-BACTERIAL AGENTS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CHELATING AGENTS; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; MALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; MOTOR ACTIVITY; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA;

ANIMALIA; MUS;

EID: 77957851846     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0202-7     Document Type: Article

References (44)

1. Bo L, Geurts JJ, Mork SJ et al (2006) Grey matter pathology in multiple sclerosis. Acta Neurol Scand Suppl 183:48-50
2. Kutzelnigg A, Faber-Rod JC, Bauer J et al (2007) Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 17:38-44 (Pubitemid 46310678)
3. Bo L, Vedeler CA, Nyland H et al (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9:323-331 (Pubitemid 36958014)
4. Skripuletz T, Bussmann JH, Gudi V et al (2010) Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol 20:231-232
5. Skripuletz T, Lindner M, Kotsiari A et al (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172:1053-1061 (Pubitemid 351520001)
6. Torkildsen O, Brunborg LA, Myhr KM et al (2008) The cuprizone model for demyelination. Acta Neurol Scand Suppl 188:72-76 (Pubitemid 351606183)
7. Blakemore WF (1973) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20: 63-72
8. Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as A model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116
9. Bakker DA, Ludwin SK (1987) Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci 78:125-137
10. Kondo A, Nakano T, Suzuki K (1987) Blood-brain barrier permeability to horseradish peroxidase in twitcher and cuprizone-intoxicated mice. Brain Res 425:186-190 (Pubitemid 17159384)
11. Kloppenburg M, Verweij CL, Miltenburg AM et al (1995) The influence of tetracyclines on T cell activation. Clin Exp Immunol 102:635-641 (Pubitemid 26013229)
12. Yrjanheikki J, Tikka T, Keinanen R et al (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with A wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500
13. Dommergues MA, Plaisant F, Verney C et al (2003) Early mi-croglial activation following neonatal excitotoxic brain damage in mice: A potential target for neuroprotection. Neuroscience 121:619-628 (Pubitemid 38367501)
14. Fan R, Xu F, Previti ML et al (2007) Minocycline reduces microglial activation and improves behavioral deficits in A transgenic model of cerebral microvascular amyloid. J Neurosci 27:3057-3063 (Pubitemid 46474134)
15. Brundula V, Rewcastle NB, Metz LM et al (2002) Targeting leukocyte MMPs and transmigration: minocycline as A potential therapy for multiple sclerosis. Brain 125:1297-1308 (Pubitemid 34587139)
16. Popovic N, Schubart A, Goetz BD et al (2002) Inhibition of autoimmune encephalomyelitis by A tetracycline. Ann Neurol 51:215-223 (Pubitemid 34111444)
17. Rehbinder C, Baneux P, Forbes D et al (1996) FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Report of the Federation of European Laboratory Animal Science Associations (FELASA). Working Group on Animal Health accepted by the FELASA Board of Management, November 1995. Lab Anim 30:193-208
18. Lindner M, Heine S, Haastert K et al (2008) Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 34:105-114
19. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Academic Press, New York
20. Lindner M, Trebst C, Heine S et al (2008) The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone-induced demyelination. Glia 56:1104-1113
21. Gudi V, Moharregh-Khiabani D, Skripuletz T et al (2009) Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 1283:127-138
22. van Gaalen MM, Steckler T (2000) Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 115: 95-106
23. Pellow S, Chopin P, File SE et al (1985) Validation of open:-closed arm entries in an elevated plus-maze as A measure of anxiety in the rat. J Neurosci Methods 14:149-167 (Pubitemid 16239568)
24. Karl T, Pabst R, von Horsten S (2003) Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55:69-83 (Pubitemid 36975689)
25. Kuhlmann T, Remington L, Maruschak B et al (2007) Nogo-A is A reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions. J Neuropathol Exp Neurol 66:238-246 (Pubitemid 46673279)
26. Li WW, Setzu A, Zhao C et al (2005) Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in A non-immune model of demyelination. J Neuroimmunol 158:58-66 (Pubitemid 39626071)
27. Sanchez Mejia RO, Ona VO, Li M et al (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48: 1393-1399 (Pubitemid 32472597)
28. Koutsoudaki PN, Skripuletz T, Gudi V et al (2009) Demyelina-tion of the hippocampus is prominent in the cuprizone model. Neurosci Lett 451:83-88
29. Norkute A, Hieble A, Braun A et al (2009) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 87:1343-1355
30. Crawford DK, Mangiardi M, Xia X et al (2009) Functional recovery of callosal axons following demyelination: A critical window. Neuroscience 164:1407-1421
31. Venturini G (1973) Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cu-prizone treatment in vivo. J Neurochem 21:1147-1151
32. Kipp M, Clarner T, Dang J et al (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118:723-736
33. Mahad D, Lassmann H, Turnbull D (2008) Review: Mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 34:577-589
34. Kim JY, Shen S, Dietz K et al (2010) HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage. Nat Neurosci 13:180-189
35. Pasquini LA, Calatayud CA, Bertone Una AL et al (2007) The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279-292
36. de Haas AH, Boddeke HW, Biber K (2008) Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56:888-894
37. de Haas AH, Boddeke HW, Brouwer N et al (2007) Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia 55:1374-1384 (Pubitemid 47328940)
38. Liebetanz D, Merkler D (2006) Effects of commissural de-and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol 202:217-224 (Pubitemid 44344263)
39. Franco-Pons N, Torrente M, Colomina MT et al (2007) Behavioral deficits in the cuprizone-induced murine model of demye-lination/remyelination. Toxicol Lett 169:205-213 (Pubitemid 46436370)
40. Hibbits N, Pannu R, John WT et al (2009) Cuprizone demye-lination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination. ASN Neuro 1
41. Makinodan M, Yamauchi T, Tatsumi K et al (2009) Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 33:978-985
42. Bilousova TV, Dansie L, Ngo M et al (2009) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94-102
43. Henry CJ, Huang Y, Wynne A et al (2008) Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation 5:15 (Pubitemid 351803827)
44. Chacur M, Lambertz D, Hoheisel U et al (2008) Role of spinal microglia in myositis-induced central sensitisation: An immu-nohistochemical and behavioural study in rats. Eur J Pain 13:915-923